Summit Rock Advisors, LP
New York, NY · CIK 1540951 · 13F filing filed 2022-08-01
SEC-registered investment adviser since 2007 · limited partnership
- Assets managed$26.2bn
- Staff74 · 41 in investment roles
- Main clients (by assets)Private funds 57%, High net worth individuals 27%, Charities 15%
- Private funds21 (6 hedge) · $15.0bn gross assets
- Websitesummit-rock.com
- Form ADV · 2026-03-27SEC adviser record
- Kindhedge funds, private equity, futures
- Others nearbyNew York, NY
As an employer
- Offices in1 country
- Private fundshedge 6, private equity 15
$122.4m
reported value
-25.1% vs Q1 2022
8positions
100.0%in top 10
1 new
1 added
1 reduced
1 sold out
vs Q1 2022
Holdings, Q2 2022
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| SELECT SECTOR SPDR TR XLE | $60.3m49.27% | Reduced -586.5k |
| ISHARES TR IWN | $57.2m46.72% | Added +117.2k |
| VANGUARD INTL EQUITY INDEX F VT | $2.7m2.18% | Unchanged |
| ADVANCED DRAIN SYS INC DEL WMS | $671.0k0.55% | New |
| DAY ONE BIOPHARMACEUTICALS I COM | $593.0k0.48% | Unchanged |
| CLOVER HEALTH INVESTMENTS CO CLOV | $451.0k0.37% | Unchanged |
| PHATHOM PHARMACEUTICALS INC PHAT | $288.0k0.24% | Unchanged |
| DYNE THERAPEUTICS INC DYN | $240.0k0.20% | Unchanged |
Sold out since Q1 2022
| Security | Value then |
|---|---|
| MONDAY COM LTD MNDY | $265.0k1.7k shares |